Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial

Kausik K. Ray, Roel P.T. Troquay, Frank L.J. Visseren, Lawrence A. Leiter, R. Scott Wright, Sheikh Vikarunnessa, Zsolt Talloczy, Xiao Zang, Pierre Maheux, Anastasia Lesogor, Ulf Landmesser

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences